Press release
Crohn's Disease Market Size is anticipated to grow at a CAGR of 7.6% for the study period 2018-2030 | DelveInsight
Crohn's Disease Market
DelveInsight's 'Crohn's Disease Market Insights, Epidemiology, and Market Forecast - 2030' report delivers an in-depth understanding of the Crohn's Disease, historical and forecasted epidemiology as well as the Crohn's Disease market trends in the United States.
To get detailed information about Crohn's Disease Market Dynamics, Click here @ https://www.delveinsight.com/report-store/crohns-disease-cd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of Crohn's Disease Market are:
• In the year 2020, the total prevalent case of Crohn's Disease was 825,165 cases in the United States which are expected to grow during the forecast period, i.e., 2021-2030.
• The disease epidemiology covered in the report provides historical as well as forecasted Crohn's Disease epidemiology [segmented as Total Prevalent Cases of Crohn's Disease, Total Diagnosed Cases of Crohn's Disease, Age-specific cases of Crohn's Disease, Severity-specific Cases of Crohn's Disease, and Treated cases of Crohn's Disease] in the United States from 2018 to 2030.
• The US FDA-approved biologics for the treatment of Crohn's Disease include infliximab, adalimumab, certolizumab, vedolizumab, natalizumab, ustekinumab.
• Growth of the Crohn's Disease market is expected to be mainly driven by the entry of novel therapies with better clinical profile and patient convenient RoA, increase in market penetration of targeted/advanced therapies, advances in research and development, new biomarkers for diagnosis of Crohn's Disease, and increasing prevalence of Crohn's Disease.
To get detailed information about Crohn's Disease Epidemiology Insight, Click here @ https://www.delveinsight.com/report-store/crohns-disease-cd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Crohn's Disease Report Scope
• The report covers the descriptive overview of Crohn's Disease, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
• Comprehensive insight has been provided into the Crohn's Disease epidemiology and treatment in the 7MM.
• Additionally, an all-inclusive account of both the current and emerging therapies for Crohn's Disease are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
• A detailed review of Crohn's Disease market; historical and forecasted is included in the report, covering drug outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Crohn's Disease market.
Crohn's Disease Therapies covered:
• Jyselica/Filgotinib (Gilead Sciences/Galapagos NV)
• Rinvoq/Upadacitinib (AbbVie)
• Etrolizumab/RG 7413 (Hoffmann-La Roche/Genentech)
• Ozanimod/Zeposia (Celgene)
• Skyrizi/Risankizumab (AbbVie/Boehringer Ingelheim)
• Brazikumab/MEDI-2070 (Astrazeneca)
• Alofisel/Darvadstrocel (Takeda/TiGenix)
• Mirikizumab/LY-3074828 (Eli Lilly and Company)
• RHB-104 (RedHill Biopharma)
• Etrasimod/APD334 (Arena Pharmaceuticals)
• Tremfya/Guselkumab (Janssen)
• Deucravacitinib/BMS-986165 (Bristol-Myers Squibb)
• Tesnatilimab/JNJ-64304500 (Janssen)
• Sibofimloc/EB8018 (Takeda/Enterome)
• BT-11 (Landos Biopharma)
• UTTR1147A/RG 7880 (Genentech)
• TD-1473/JNJ 8398 (Theravance Biopharma/Janssen)
• JNJ-67864238/PTG 200 (Protagonist Therapeutics/Janssen)
• SHR0302 (Reistone Biopharma)
• Ryoncil/Remestemcel-L (Mesoblast)
• Ritlecitinib/Brepocitinib (Pfizer)
Click here to get detailed information about Crohn's Disease Therapies and Treatment, Click here @ https://www.delveinsight.com/report-store/crohns-disease-cd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of content
1. Key Insights
2. Executive Summary of Crohn's Disease
3. Competitive Intelligence Analysis for Crohn's Disease
4. Crohn's Disease: Market Overview at a Glance
5. Crohn's Disease: Disease Background and Overview
6. Patient Journey
7. Crohn's Disease Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Crohn's Disease Treatment
11. Marketed Products
12. Emerging Therapies
13. Crohn's Disease: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Crohn's Disease
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Detailed TOC: To get detailed information about Crohn's Disease Market Dynamics, Click here @ https://www.delveinsight.com/report-store/crohns-disease-cd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
About DelveInsight
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical, Bio-Tech, and Medical devices companies formulate prudent business decisions for improving their performances to stay ahead of the competitors.
Contact Us
Ankit Nigam
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crohn's Disease Market Size is anticipated to grow at a CAGR of 7.6% for the study period 2018-2030 | DelveInsight here
News-ID: 2598212 • Views: …
More Releases from DelveInsight Business Research
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease…
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product…
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth.
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices…
More Releases for Crohn
Global IBD Ulcerative Colitis And Crohn S Disease Treatment Industry Poised for …
The IBD Ulcerative Colitis And Crohn S Disease Treatment Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as…
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025.
This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson
Pfizer
Sanofi
Merck
GSK
AbbVie
Takeda
Ferring
UCB
Boehringer Ingelheim
Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Crohn Disease can be split into
Small Intestine and Ileocephalitis
Colon Disease
Market segment…
